Nifedipine Tablet, Extended Release
Product Images NDC 55154-4157

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 55154-4157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (C98ecf77 Ae9a 438b 9bad Ffbed25d95bc 00)

NIFEdipine is a medication that comes in extended-release tablets of 60mg each. These tablets should be swallowed whole and are not intended to be bitten or divided. The product insert contains the full prescribing information, precautions, and warnings. The tablets should be stored between 20° to 25° C (68°to 77° F) and protected from light and moisture. The Unit Dose package is not child-resistant and is intended for institutional use only. This medication is distributed by Ingenus Pharmaceuticals, LLC and Major Pharmaceuticals in the USA, and by Cardinal Health.*

FDA Label Image

01 (Image 01)

FDA Label Image

02 (Image 02)

This text presents the adverse effects percentages of Nifedipine extended-release tablets compared to placebo. The adverse effects reported include headache, fatigue, dizziness, constipation, and nausea. The table shows the percentage of patients who reported each of these side effects while taking the medication (Nifedipine) and while taking a placebo.*

FDA Label Image

03 (Image 03)

This is a chart of adverse effects reported by patients taking Nifedipine Capsules compared to placebo. The chart shows the percentage of patients who reported each adverse effect out of a total of 226 patients taking Nifedipine Capsules and 235 patients taking placebo. The adverse effects reported include dizziness, lightheadedness, giddiness, flushing, heat sensation, headache, weakness, nausea, heartburn, muscle cramps, tremor, peripheral edema, nervousness, mood changes, palpitations, dyspnea, cough, wheezing, nasal congestion, and sore throat.*

FDA Label Image

04 (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.